Search studies using keywords
1,851 Studies in the database containing data with -log p ≥ 0 (showing 301-320)
Pages: << 11 12 13 14 15 16 17 18 19 20 >>
No data sets (in No Studies) added to Browser
Identifier Name Phenotype(s) Total p-values Related citationsAdd data sets to Browser Related data
HGVST1550 plus GWAS of Vascular dementia 
  • Vascular dementia
1
HGVST1551 plus GWAS of Dietary macronutrient intake 
  • Dietary macronutrient intake (Protein - model 2)
  • Dietary macronutrient intake (Carbohydrates - model 2)
3
HGVST1552 plus GWAS of Drinking behavior 
  • Drinking behavior
1
HGVST1553 plus GWAS of Menopause (age at onset) 
  • Menopause (age at onset)
8
HGVST1554 plus GWAS of Serum ceruloplasmin levels 
  • Serum ceruloplasmin levels
1
HGVST1541 plus GWAS of Circulating vasoactive peptide levels 
  • Circulating vasoactive peptide levels (ET)
  • Circulating vasoactive peptide levels (ADM)
7
HGVST1542 plus GWAS of Coronary heart disease 
  • Coronary heart disease
5
HGVST1543 plus GWAS of Tumor biomarkers 
  • Tumor biomarkers (AFP)
  • Tumor biomarkers (CA19-9)
  • Tumor biomarkers (CEA)
11
HGVST1544 plus GWAS of Intelligence (childhood) 
  • Intelligence (childhood)
6
HGVST1545 plus GWAS of Thyroid stimulating hormone 
  • Thyroid stimulating hormone
1
HGVST1546 plus GWAS of Monocyte count 
  • Monocyte count
6
HGVST1547 plus GWAS of Thyroid hormone levels 
  • Thyroid hormone levels (TSH)
  • Thyroid hormone levels (TSH - Males)
  • Thyroid hormone levels (FT4-Females)
  • Thyroid hormone levels (TSH - Females)
  • Thyroid hormone levels (FT4)
  • Thyroid hormone levels (FT4-Males)
60
HGVST1535 plus GWAS of Bilirubin levels 
  • Bilirubin levels (Total bilirubin)
  • Bilirubin levels (Indirect bilirubin)
  • Bilirubin levels (Direct bilirubin)
10
HGVST1536 plus GWAS of Presence of antiphospholipid antibodies 
  • Presence of antiphospholipid antibodies (ACL, LAC, or anti-B2 GPI)
  • Presence of antiphospholipid antibodies (ACL, LAC, or Anti-B2 GPI)
  • Presence of antiphospholipid antibodies (ACL)
  • Presence of antiphospholipid antibodies (LAC)
  • Presence of antiphospholipid antibodies (anti-B2 GPI)
13
HGVST1537 plus GWAS of Epstein-Barr virus immune response (EBNA-1) 
  • Epstein-Barr virus immune response (EBNA-1) (Quantitative)
  • Epstein-Barr virus immune response (EBNA-1) (Conditional on rs477515 - Quantitative)
2
HGVST1538 plus GWAS of Longevity 
  • Longevity
1
HGVST1539 plus GWAS of Sickle cell anemia (haemolysis) 
  • Sickle cell anemia (haemolysis)
4
HGVST1540 plus GWAS of Tetralogy of Fallot 
  • Tetralogy of Fallot
6
HGVST1528 plus GWAS of Thiazide-induced adverse metabolic effects in hypertensive patients 
  • Thiazide-induced adverse metabolic effects in hypertensive patients (AA-triglyceride response)
  • Thiazide-induced adverse metabolic effects in hypertensive patients (EA-triglyceride response)
  • Thiazide-induced adverse metabolic effects in hypertensive patients (EA-glucose response)
  • Thiazide-induced adverse metabolic effects in hypertensive patients (AA-glucose response)
59
HGVST1529 plus GWAS of Bone mineral density 
  • Bone mineral density (Cortical vBMD)
  • Bone mineral density (Trabecular vBMD)
  • Bone mineral density (Cortical vBMD - conditional on rs1021188)
7